This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
Novavax’s vaccine provided little protection against COVID-19 infection, according to a new study.
Two weeks after the second dose of the two-dose primary series, the effectiveness against infection was just 31 percent, researchers in Italy estimated.
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
